Literature DB >> 8999911

Saturation of the endocytic pathway for the transferrin receptor does not affect the endocytosis of the epidermal growth factor receptor.

R A Warren1, F A Green, C A Enns.   

Abstract

Cell-surface receptors that undergo clathrin-mediated endocytosis contain short amino acid sequences in their cytoplasmic domain that serve as internalization signals. Interactions between these sequences and components of the endocytic machinery should become limiting upon overexpression of the constitutively recycling transferrin receptor (TfR). A tetracycline-responsive system was used to induce overexpression of the TfR up to 20-fold in HeLa cells. Internalization assays indicate the rate of 125I-transferrin uptake per surface TfR is reduced by a factor of 4 in induced cells. Consistent with endocytosis being the rate-limiting step, TfRs shift from an endosomal to more of a plasma membrane distribution with TfR overexpression. The clathrin-associated protein AP-2 has been proposed to interact directly with the cytoplasmic domain of many receptors, yet no changes in the amount or distribution of AP-2 were detected in induced cells. The internalization rate for the epidermal growth factor receptor was also measured, with or without induction of TfR expression. Even though endocytosis of the TfR is saturated in induced cells, 125I-labeled epidermal growth factor continues to be internalized at a rate identical to that seen in uninduced cells. We propose that there are different limiting steps for the endocytosis of these two receptors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8999911     DOI: 10.1074/jbc.272.4.2116

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Cytoplasmic domain of herpes simplex virus gE causes accumulation in the trans-Golgi network, a site of virus envelopment and sorting of virions to cell junctions.

Authors:  T N McMillan; D C Johnson
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Multivalent display and receptor-mediated endocytosis of transferrin on virus-like particles.

Authors:  Deboshri Banerjee; Allen P Liu; Neil R Voss; Sandra L Schmid; M G Finn
Journal:  Chembiochem       Date:  2010-06-14       Impact factor: 3.164

Review 3.  Clathrin-dependent endocytosis.

Authors:  Seyed Ali Mousavi; Lene Malerød; Trond Berg; Rune Kjeken
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

4.  Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents.

Authors:  Volker Mailänder; Myriam Ricarda Lorenz; Verena Holzapfel; Anna Musyanovych; Karin Fuchs; Markus Wiesneth; Paul Walther; Katharina Landfester; Hubert Schrezenmeier
Journal:  Mol Imaging Biol       Date:  2008-02-23       Impact factor: 3.488

Review 5.  Regulation of G protein-coupled receptor signaling by plasma membrane organization and endocytosis.

Authors:  Zara Y Weinberg; Manojkumar A Puthenveedu
Journal:  Traffic       Date:  2019-01-11       Impact factor: 6.215

Review 6.  Protein sorting within the MHC class II antigen-processing pathway.

Authors:  M S Marks
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

7.  Endocytic clathrin-coated pit formation is independent of receptor internalization signal levels.

Authors:  F Santini; M S Marks; J H Keen
Journal:  Mol Biol Cell       Date:  1998-05       Impact factor: 4.138

8.  Multiple endosomal recycling pathways in rat adipose cells.

Authors:  K V Kandror; P F Pilch
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

9.  Visualizing Coronavirus Entry into Cells.

Authors:  Aleksandra Milewska; Katarzyna Owczarek; Artur Szczepanski; Krzysztof Pyrc
Journal:  Methods Mol Biol       Date:  2020

10.  Cargo- and adaptor-specific mechanisms regulate clathrin-mediated endocytosis.

Authors:  Marcel Mettlen; Dinah Loerke; Defne Yarar; Gaudenz Danuser; Sandra L Schmid
Journal:  J Cell Biol       Date:  2010-03-15       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.